| Title |
Publication Date |
| Managing Overweight and Obese Patients: Weight Loss-Related Health Benefits in Overweight and Obese Adults |
07/01/2020 |
| Managing Overweight and Obese Patients: Recommended Diet Options* for Overweight and Obese Individuals |
07/01/2020 |
| Managing Overweight and Obese Patients: FDA-Approved Medications for Weight Loss |
07/01/2020 |
| Managing Overweight and Obese Patients: Resources for More Information |
07/01/2020 |
| Managing Overweight and Obese Patients: Behavior Tips for Losing Weight |
07/01/2020 |
| HIV: Emerging Trends in Prevention & Treatment: Abbreviations Used in This Issue |
06/01/2020 |
| HIV - Emerging Trends in Prevention & Treatment: Recommended PrEP and PEP Regimens |
06/01/2020 |
| HIV: Emerging Trends in Prevention & Treatment: Commonly used Single Tablet Regimens (STR) for the Treatment of HIV in Adults |
06/01/2020 |
| HIV: Emerging Trends in Prevention & Treatment: DHHS Initial ART Recommendations for Most Treatment-Naïve Adult Patients with HIV |
06/01/2020 |
| HIV: Emerging Trends in Prevention & Treatment: Strategies for Taking Your Medications As Scheduled |
06/01/2020 |
| HIV: Emerging Trends in Prevention & Treatment: Resources for More Information |
06/01/2020 |
| Heart Failure: ACCF/AHA Stages and NYHA Functional Classification of HF |
05/01/2020 |
| Heart Failure: Neurohormonal Systems in Heart Failure |
05/01/2020 |
| Heart Failure: Selected Medications for Heart Failure Management |
05/01/2020 |
| Heart Failure: Selected Drugs/Drug Classes That Can Worsen Heart Failure |
05/01/2020 |
| New Drugs 2019 - Selected New Drugs |
04/01/2020 |
| New Drugs 2019: Patient Information: Minocycline Foam (Amzeeq™) |
04/01/2020 |
| New Drugs 2019: Patient Information: Trifarotene Cream (Aklief®) |
04/01/2020 |
| New Drugs 2019: Patient Information: Bremelanotide (Vylessi™) |
04/01/2020 |
| New Drugs 2019: Brief Descriptions of Selected New Drugs and Selected New Drug Combinations |
04/01/2020 |
| New Drugs 2019 |
04/01/2020 |
| New Drugs 2019: Patient Information: Lemborexant (Dayvigo™) |
04/01/2020 |
| New Drugs 2019: Patient Information: Lasmiditan (Reyvow™) and Ubrogepant (Ubrelvy™) |
04/01/2020 |
| New Drugs 2019: Patient Information: Solriamfetol (Sunosi™) |
04/01/2020 |
| New Drugs 2019: Patient Information: Cladribine (Mavenclad®) and Siponimod (Mayzent®) |
04/01/2020 |
| New Drugs 2019: Biosimilars Approved in 2019 |
04/01/2020 |
| Asthma Management: New Developments - Poor Medication Adherence In Asthma |
03/01/2020 |
| Asthma Management: New Developments - Selected ICS and ICS-LABA Combination Inhalers for Asthma |
03/01/2020 |
| Asthma Management: New Developments - Potential Asthma Triggers |
03/01/2020 |
| Asthma Management: New Developments - Resources for More Information |
03/01/2020 |
| Asthma Management: New Developments - Biologic Agents Approved for Asthma Treatment |
03/01/2020 |
| Diabetes Management Update A Patient-Centered Approach ADA Initial Recommendations for Hypertension Management |
02/01/2020 |
| Diabetes Management Update A Patient-Centered Approach Statin Recommendations in Persons with Diabetes |
02/01/2020 |
| Diabetes Management Update A Patient-Centered Approach GLP-1 Agonists Medication Comparison |
02/01/2020 |
| Diabetes Management Update A Patient-Centered Approach SGLT-2 Inhibitors Medication Comparison |
02/01/2020 |
| Diabetes Management Update A Patient-Centered Approach Caring for Your Diabetes |
02/01/2020 |
| Postmenopausal Osteoporosis: Selected Recommendations for Osteoporosis Screening and Treatment in Women |
01/01/2020 |
| Postmenopausal Osteoporosis: FDA Approved Medications for the Prevention and/or Treatment of Postmenopausal Osteoporosis |
01/01/2020 |
| Postmenopausal Osteoporosis: Assessment for a Bisphosphonate “Drug Holiday” |
01/01/2020 |
| Postmenopausal Osteoporosis: Resources for More Information |
01/01/2020 |
| Postmenopausal Osteoporosis: Medications for the Treatment and Prevention of Osteoporosis |
01/01/2020 |
| Postmenopausal Osteoporosis: Medications for the Treatment and Prevention of Osteoporosis |
01/01/2020 |
| Urinary Tract Infection Uncomplicated Infections in Women: First Line Treatment for Uncomplicated Recurrent UTI |
12/01/2019 |
| Recurrent Uncomplicted Urinary Tract Infections in Women: AUA/CUA/SUFU Diagnosis & Treatment Algorithm |
12/01/2019 |
| Urinary Tract Infection - Uncomplicated Infections in Women: Alternate Oral Antibiotics for Recurrent UTI |
12/01/2019 |
| Antibiotic Prophylaxis for Recurrent Urinary Tract Infection |
12/01/2019 |
| The Hypothyroid Patient: Thyroid Hormone Levels |
11/01/2019 |
| The Hypothyroid Patient: Common Drug Interactions with Thyroid Hormone Replacement |
11/01/2019 |
| The Hypothyroid Patient: Treatment Options for Hypothyroidism |
11/01/2019 |
| The Hypothyroid Patient: Possible Drug Interactions with Levothyroxine |
11/01/2019 |
| Surviving and Thriving with ADHD Part 2 Clinical Presentation and Diagnostic Criteria for ADHD |
11/01/2019 |
| Surviving and Thriving with ADHD Part 2: Coexisting Conditions with ADHD |
11/01/2019 |
| Surviving and Thriving with ADHD Part 1: Stimulant Drugs Used in the Treatment of ADHD |
10/01/2019 |
| Surviving and Thriving with ADHD: Part 1 - Nonstimulant Drugs for ADHD: Dosing and Adverse Effect Monitoring |
10/01/2019 |
| Surviving and Thriving with ADHD: Part 1 - Nonstimulant Drugs for ADHD: Selected Stimulants for Treatment of ADHD |
10/01/2019 |
| Surviving and Thriving with ADHD: Part 1 - Nonstimulant Drugs for ADHD:Stimulant Side Effects and Their Management |
10/01/2019 |
| Medication Safety Update: Adverse Drug Event (ADE) Prevention Strategies in the Community Setting |
09/01/2019 |
| Medication Safety Update: Examples of Look-Alike and Sound-Alike Medications |
09/01/2019 |
| Medication Safety Update - Case Study: Deprescribing Long-Term PPI Therapy |
09/01/2019 |
| Medication Safety Update: Medication Error and ADE Reporting Systems |
09/01/2019 |
| Medication Safety Update: Pharmacovigilance Case Example |
09/01/2019 |
| Medication Safety Update: Poison Prevention Tips |
09/01/2019 |
| Medication Safety Update: Resources for More Information |
09/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Corresponding Responsibility Doctrine |
07/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Opioid Prescription Concerns: Red Flags |
07/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Open-Ended Patient Education |
07/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Examples of 50 and 90 Morphine Milligram Equivalents (MME) |
07/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Pharmacist Resources |
07/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Tips for Safe Opioid Use |
07/01/2019 |
| Pharmacy Law - A Focus on Opioid Prescriptions: Patient Resources for More Information |
07/01/2019 |
| Heartburn: Appropriate Use of OTC Medications Exclusions to Self-Treatment of Heartburn |
07/01/2019 |
| Heartburn - Appropriate Use of OTC Medications: Selected Nonprescription Medications Used to Treat Heartburn |
07/01/2019 |
| Heartburn - Appropriate Use of OTC Medications: Selected Drug Interactions with OTC Heartburn Medications |
07/01/2019 |
| Heartburn - Appropriate Use of OTC Medications: Treatment Algorithm for Self-Care of Heartburn |
07/01/2019 |
| Heartburn - Appropriate Use of OTC Medications: Lifestyle Changes That May Improve Heartburn |
07/01/2019 |
| Heartburn - Appropriate Use of OTC Medications: Nonprescription Medications for Heartburn or GERD* |
07/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: Daily Doses for High, Moderate, and Low-Intensity Statin Therapy |
06/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: Determinants of " Very High Risk" in Patients With Clinical ASCVD |
06/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: Using the ASCVD Risk Estimator |
06/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: Secondary Prevention |
06/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: Primary Prevention |
06/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: What is Your Risk? |
06/01/2019 |
| Cholesterol Management - Understanding the 2018 Guideline: Resources for More Information |
06/01/2019 |
| Cannabidiol (CBD): Prescription CBD Products |
05/01/2019 |
| Cannabidiol (CBD): Examples of Oral Non-Prescription Hem p-derived Products Containing CBD Oil |
05/01/2019 |
| Cannabidiol (CBD): Examples of Canabidiol (CBD) Drug Inte ractions |
05/01/2019 |
| New Drugs 2018: Selected New Drugs |
04/01/2019 |
| New Drugs 2018: Elagolix |
04/01/2019 |
| New Drugs 2018: Erenumab, Fremanezumab, Galcanezumab |
04/01/2019 |
| New Drugs 2018: Omadacycline |
04/01/2019 |
| New Drugs 2018: Baloxavir |
04/01/2019 |
| New Drugs 2018: Prucalopride |
04/01/2019 |
| New Drugs 2018: Sarecycline |
04/01/2019 |
| New Drugs 2018: Brief Descriptions of Selected New Drugs |
04/01/2019 |
| New Drugs 2018: New HIV Drugs and HIV Drug Combinations |
04/01/2019 |
| New Drugs 2018: Selected New Formulations or New Indications for Previously Approved Drugs |
04/01/2019 |
| Dry Eye Disease: Factors Associated With Dry Eye Disease |
03/01/2019 |
| Dry Eye Disease: Four-Step Approach to the Management of Dry Eye Disease |
03/01/2019 |
| Dry Eye Disease: Self-Care Questions For Patients |
03/01/2019 |
| Dry Eye Disease: Selected Nonprescription Lubricants For Dry Eye Disease |
03/01/2019 |
| Dry Eye Disease: Selected Prescription Medications For the Management of DED and Associated Conditions |
03/01/2019 |
| Dry Eye Disease: Resources for More Information |
03/01/2019 |
| Dry Eye Disease: How to Put Drops or Ointment in Your Eyes |
03/01/2019 |
| Oral Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer: General Treatment Approach for Newly Diagnosed Stage IV NSCLC Adenocarcinoma |
02/01/2019 |
| Oral Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer: Targeted Oral Therapies for Lung Cancer |
02/01/2019 |
| Oral Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer: Targeted Oral Therapies for Lung Cancer - Continued |
02/01/2019 |
| Oral Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer: Management of Dermatologic Adverse Effects of Targeted Oral Therapies |
02/01/2019 |
| Oral Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer - Patient Advocacy: Oral Chemotherapy Parity |
02/01/2019 |
| Oral Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer: Signs and Symptoms of Non-Small Cell Lung Cancer |
02/01/2019 |
| Heartburn Appropriate Use of OTC Medications: Exclusions to Self-Treatment of Heartburn |
01/01/2019 |
| Heartburn Appropriate Use of OTC Medications: Selected Nonprescription Medications Used to Treat Heartburn |
01/01/2019 |
| Heartburn Appropriate Use of OTC Medications: Selected Drug Interactions with OTC Heartburn Medications |
01/01/2019 |
| Heartburn Appropriate Use of OTC Medications: Treatment Algorithm for Self-Care of Heartburn |
01/01/2019 |
| Heartburn Appropriate Use of OTC Medications: Nonprescription Medications for Heartburn or GERD* |
01/01/2019 |
| Heartburn Appropriate Use of OTC Medications: Lifestyle Changes That May Improve Heartburn |
01/01/2019 |
| Direct-Acting Oral Anticoagulants: Advantages of Warfarin and DOACs |
12/01/2018 |
| Direct-Acting Oral Anticoagulants: Recommendations for Antithrombotic Therapy in Non-valvular Atrial Fibrillation |
12/01/2018 |
| Direct Acting Oral Anticoagulants: Indications, Dose & Dose Adjustments |
12/01/2018 |
| Direct Acting Oral Anticoagulants: Factors to Consider in DOAC Selection |
12/01/2018 |
| Direct Acting Oral Anticoagulants: Resources for More Information |
12/01/2018 |
| Direct Acting Oral Anticoagulants: Use, Dosing & Points To Remember |
12/01/2018 |
| Direct Acting Oral Anticoagulants: Pharmacokinetic Drug Interactions with DOACs |
12/01/2018 |
| Direct Acting Oral Anticoagulants: DOAC Procedure Temporary Interruption Guidance |
12/01/2018 |
| Managing Chronic Pain: Classification of Chronic Pain Types |
11/01/2018 |
| Managing Chronic Pain: Relative Selectivity of NSAIDs as Inhibitors of COX-1 and COX-2 |
11/01/2018 |
| Managing Chronic Pain: Commonly Used Opioid Medications for Pain Management |
11/01/2018 |
| Managing Chronic Pain: Resources for More Information |
11/01/2018 |
| Managing Chronic Pain: Important Opioid Safety Measures |
11/01/2018 |
| Managing Chronic Pain: Select Antidepressants and Anticonvulsants Used for Pain Management |
11/01/2018 |
| New Considerations in Diabetes Management: Comparison of SGLT2 Inhibitors |
10/01/2018 |
| New Considerations in Diabetes Management: Newer Insulin Analog Product Characteristics |
10/01/2018 |
| New Considerations in Diabetes Management: Comparison of Personal Continuous Glucose Monitoring Devices |
10/01/2018 |
| New Considerations in Diabetes Management: Differences in ADA and AACE/ACE Type 2 Diabetes Treatment Recommendations |
10/01/2018 |
| New Considerations in Diabetes Management: Resources for More Information |
10/01/2018 |
| Influenza Update: Populations at High Risk For Flu Complications |
09/01/2018 |
| Influenza Update: Vaccine Products Available for 2018-2019 |
09/01/2018 |
| Influenza Update: Dosing Algorithm for Children Less Than 9 Years |
09/01/2018 |
| Influenza Update: Influenza Vaccine Precautions & Contraindications |
09/01/2018 |
| Influenza Update: Antiviral Medications |
09/01/2018 |
| Managing Psoriasis: Classification of Cutaneous Forms of Psoriasis |
07/01/2018 |
| Managing Psoriasis: Selected Medications for Psoriasis #1 |
07/01/2018 |
| Managing Psoriasis: Selected Medications for Psoriasis #2 |
07/01/2018 |
| Managing Psoriasis: Resources for More Information |
07/01/2018 |
| Managing Psoriasis: Common Topical Treatments for Psoriasis |
07/01/2018 |
| Medication Adherence: Selected Methods for Measuring Adherence |
06/01/2018 |
| Medication Adherence: Dimensions That Influence Medication Adherence |
06/01/2018 |
| Medication Adherence: "SIMPLE"Acronym to Improve Adherence |
06/01/2018 |
| Medication Adherence: Tips for Remembering To Take Your Medication |
06/01/2018 |
| Medication Adherence: Resources for More Information |
06/01/2018 |
| Medication Adherence: Resources to Improve Medication Adherence |
06/01/2018 |
| Hypertension Update 2018: Hypertension Treatment and Follow-up - 2017 ACC/AHA Guideline |
05/01/2018 |
| Hypertension Update 2018: Nondrug Approaches For Blood Pressure Lowering |
05/01/2018 |
| Hypertension Update 2018: Recommended First Line Antihypertensive Drugs |
05/01/2018 |
| Hypertension Update 2018: Resources for More Information |
05/01/2018 |
| Hypertension Update 2018: Key Lifestyle Recommendations For People with High Blood Pressure |
05/01/2018 |
| New Drugs 2017: Selected New Drugs |
04/01/2018 |
| New Drugs 2017: Patient Information - Deutetrabenazine (Austedo®) |
04/01/2018 |
| New Drugs 2017: Patient Information - Betrixaban (Bevyxxa®) |
04/01/2018 |
| New Drugs 2017: Patient Information - Valbenazine (Ingrezza™) |
04/01/2018 |
| New Drugs 2017: Patient Information - Dupilumab (Dupixent®) |
04/01/2018 |
| New Drugs 2017: Brief Descriptions of Selected New Drugs |
04/01/2018 |
| New Drugs 2017: Patient Information - Glecaprevir / Pibrentasvir (MavyretTM) |
04/01/2018 |
| New Drugs 2017: Patient Information - Guselkumab (TremfyaTM) |
04/01/2018 |
| New Drugs 2017: Patient Information - Neratinib (NerlynxTM) |
04/01/2018 |
| New Drugs 2017: Patient Information - Secnidazole (Solosec™) |
04/01/2018 |
| New Drugs 2017: Patient Information: Netarsudil (Rhopressa®) and Latanoprostene bunod (VyzultaTM) |
04/01/2018 |
| New Drugs 2017: Patient Information - Safinamide (Xadago®) |
04/01/2018 |
| Depression: More Reasons & Options for Recovery: Second Generation Serotonergic Antidepressants |
03/01/2018 |
| Depression: More Reasons & Options for Recovery - Multiple Mechanism Second Generation Antidepressants |
03/01/2018 |
| Depression: More Reasons & Options for Recovery: Resources for More Information |
03/01/2018 |
| Depression: More Reasons & Options for Recovery - Second Generation Antidepressants: Side Effects and Management |
03/01/2018 |
| Depression: More Reasons & Options for Recovery - Complementary Treatments of Depression |
03/01/2018 |
| HIV Infection - An Update on Antiretroviral Therapy: Abbreviations |
02/01/2018 |
| HIV Infection - An Update on Antiretroviral Therapy: Single Tablet Fixed Dose Combination (FDC) Regimens for Initial HIV Treatment in Treatment-Naïve PatientsA |
02/01/2018 |
| HIV Infection - An Update on Antiretroviral Therapy: Selected FDA-Approved Antiretroviral Agents for Treatment of HIV InfectionA |
02/01/2018 |
| HIV Infection - An Update on Antiretroviral Therapy: DHHS Antiretroviral Therapy (ART) Recommendations for Initial HIV Therapy in Treatment Naïve Patients |
02/01/2018 |
| HIV Infection - An Update on Antiretroviral Therapy: Medication Adherence Strategies |
02/01/2018 |
| HIV Infection - An Update on Antiretroviral Therapy: Resources |
02/01/2018 |
| Fluoroquinolones Warnings & Side Effects - What You Need to Know Oral Fluoroquinolones: Selected Indications and Dosing Considerations |
01/01/2018 |
| Fluoroquinolones Warnings & Side Effects - What You Need to Know: Selected Drug Interactions |
01/01/2018 |
| Fluoroquinolones Warnings & Side Effects - What You Need to Know: Preventing Antibiotic Resistance |
01/01/2018 |
| Fluoroquinolones Warnings & Side Effects - What You Need to Know: Rare, Serious Fluoroquinolone Side Effects |
01/01/2018 |
| Fluoroquinolones Warnings & Side Effects - What You Need to Know: Resources for More Information |
01/01/2018 |
| Fluoroquinolones Warnings & Side Effects - What You Need to Know: Drugs That Can Increase Risk for Torsades de Pointes |
01/01/2018 |
| Smoking Cessation For the Busy Clinician: Examples of Significant Drug Interactions With Tobacco Smoke |
12/01/2017 |
| Smoking Cessation For the Busy Clinician: Smoking Cessation Counseling Tips |
12/01/2017 |
| Smoking Cessation For the Busy Clinician Medications for Smoking Cessation: Treatment Comparison Meta-Analysis |
12/01/2017 |
| Smoking Cessation For the Busy Clinician: FDA-Approved Medications for Smoking Cessation |
12/01/2017 |
| Smoking Cessation For the Busy Clinician: Resources for More Information |
12/01/2017 |
| Smoking Cessation For the Busy Clinician: Drug Interactions with Tobacco Smoke |
12/01/2017 |
| Osteoarthritis Management: Commonly Used Analgesics for Osteoarthritis Pain |
11/01/2017 |
| Osteoarthritis Management: Common Supplements Used for OA Management |
11/01/2017 |
| Osteoarthritis Management: Some Non-Drug Options for Osteoarthritis |
11/01/2017 |
| Osteoarthritis Management: ACR and AAOS Recommendations for Medication Management of Osteoarthritis (OA) |
11/01/2017 |
| Osteoarthritis Management: Resources for More Information |
11/01/2017 |
| Diabetes Update: Categories of Prediabetes |
10/01/2017 |
| Diabetes Update: Criteria for Prediabetes Testing in Asymptomatic Adults |
10/01/2017 |
| Diabetes Update: Cardiovascular Outcomes Trials |
10/01/2017 |
| Diabetes Update: Tips To Prevent Type 2 Diabetes |
10/01/2017 |
| Immunization Update: A Focus on Medical Indications for Vaccines in Adults - Selected Routine Vaccinations |
09/01/2017 |
| Immunization Update: A Focus on Medical Indications for Vaccines in Adults - 2017 Adult Medical and Other Indications-Based Immunization Schedule |
09/01/2017 |
| Immunization Update: A Focus on Medical Indications for Vaccines in Adults - Resources for More Information |
09/01/2017 |
| Immunization Update: A Focus on Medical Indications for Vaccines in Adults - Some Vaccine Components That Can Cause Allergic Reactions |
09/01/2017 |
| Immunization Update: A Focus on Medical Indications for Vaccines in Adults - 2017 Adult Age-Based Immunization Schedule |
09/01/2017 |
| Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Traditional Compounding Requirements under 503A |
07/01/2017 |
| Pharmacy Law: Regulatory Developments Affecting Pharmacy Practice Compounding Quality Act - Comparison of 503A With 503B |
07/01/2017 |
| Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Drug Supply Chain Security Act - Key Provisions |
07/01/2017 |
| Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Medications That May Be Flushed |
07/01/2017 |
| Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Resources |
07/01/2017 |
| Update on Medication Errors and Adverse Drug Events: The Medication Use Process in Community Care |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: Select Causes of Medication Errors During the Medication Use Process |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: IOM Recommendations Specific to Pharmacy to Prevent Medication Errors |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: Supportive Evidence Validates Services Provided by Pharmacists |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: Select ISMP Risk Reduction Strategies for Medication Errors |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: Steps in Medication Reconciliation |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: Medication Safety Resources |
06/01/2017 |
| Update on Medication Errors & Adverse Drug Events: Resources for More Information |
06/01/2017 |
| Antibiotic Stewardship: CDC Recommendations for Selected Adult and Pediatric Outpatient Respiratory Conditions |
05/01/2017 |
| Core Elements of Outpatient Antibiotic Stewardship |
05/01/2017 |
| Antibiotic Stewardship: How to Help Slow the Spread of Antibiotic-Resistant Bacteria |
05/01/2017 |
| New Drugs 2016 - 2017: Selected New Drugs |
04/01/2017 |
| New Drugs 2016 - 2017: A Brief Description of Selected New Drugs or Dosage Forms |
04/01/2017 |
| Chronic Insomnia: Medications FDA-Approved for the Treatment of Insomnia |
03/01/2017 |
| Chronic Insomnia: Tips for Improving Sleep Without Medications |
03/01/2017 |
| Chronic Insomnia: Resources for More Information |
03/01/2017 |
| Hormonal Contraceptives: Steps in Providing Contraceptive Services |
02/01/2017 |
| Hormonal Contraceptives: Low-Dose Oral Contraceptives and Progestin-only Oral Contraceptives |
02/01/2017 |
| Hormonal Contraceptives: Starting Hormonal Contraceptives |
02/01/2017 |
| Hormonal Contraceptives: Resources for More Information |
02/01/2017 |
| Hormonal Contraceptives: What To Do For Missed Doses of Commonly Used Pills or The Patch |
02/01/2017 |
| Medical Marijuana: Major Cannabinoids |
01/01/2017 |
| Medical Marijuana: Selected Cannabis Dosing Methods |
01/01/2017 |
| Medical Marijuana: Resources for More Information |
01/01/2017 |
| Medical Marijuana Dosing Methods |
01/01/2017 |
| Inflammatory Bowel Disease: Selected Rating Systems for IBD Severity |
12/01/2016 |
| Biologic Agents for Inflammatory Bowel Disease |
12/01/2016 |
| Inflammatory Bowel Disease: Considerations for Boxed Warnings, Contraindications, and Other Considerations for Biologic Agents for the Treatment of CD and UC |
12/01/2016 |
| Inflammatory Bowel Disease Resources for More Information |
12/01/2016 |
| Inflammatory Bowel Disease Biologic Medications Used for IBD |
12/01/2016 |
| Hepatitis C: DAA Regimens* for Treatment-Naïve or Treatment-Experienced (Peg-IFN + RBV §) HCV Genotype 1-Infected Patients, Including Those with HIV/HCV Coinfection |
11/01/2016 |
| Hepatitis C: DAA Regimens* for Treatment-Naïve or Treatment-Experienced (Peg-IFN + RBV )§ HCV Genotype 2- and 3-Infected Patients, Including Those with HIV/HCV Coinfection |
11/01/2016 |
| Hepatitis C: Selected Common Drug Interactions of HCV Direct Acting Antiviral Agents |
11/01/2016 |
| Hepatitis C: Some Herbal Supplements People With HCV Should Avoid |
11/01/2016 |
| Some Tips for Managing Hepatitis C Medication Side Effects |
11/01/2016 |
| ADA Blood Glucose Goals |
10/01/2016 |
| Candidates for Concentrated Insulin Products |
10/01/2016 |
| Concentrated Insulin Products |
10/01/2016 |
| Basal Insulin Products - Numbers To Know |
10/01/2016 |
| Diabetes Update: The New Concentrated Insulin Products - Resources |
10/01/2016 |
| Instructions For Insulin Pen Use |
10/01/2016 |
| Managing Low Blood Sugar (Hypoglycemia) |
10/01/2016 |
| Pharmacokinetic Profiles of Selected Insulins |
10/01/2016 |
| Drug Therapy Considerations for Common Behavioral & Psychiatric Symptoms of Dementia |
09/01/2016 |
| Selected Medications Used for NPSD |
09/01/2016 |
| Dementia: Resources for More Information |
09/01/2016 |
| Non-Drug Measures For Problem Behaviors In Patients with Dementia |
09/01/2016 |
| Morphine Equivalent Dose (MED) Calculations |
07/01/2016 |
| Elements of Safe and Effective Opioid Prescribing |
07/01/2016 |
| Recommendations for Integrating the PDMP into Practice |
07/01/2016 |
| Open-Ended Patient Education |
07/01/2016 |
| Opioid Prescription Concerns: Red Flags |
07/01/2016 |
| Primary Open-Angle Glaucoma |
06/01/2016 |
| Primary Closed-Angle Glaucoma |
06/01/2016 |
| Risk Factors for Primary Glaucoma |
06/01/2016 |
| Drugs to Avoid in Glaucoma |
06/01/2016 |
| Medications for Primary Open-Angle Glaucoma |
06/01/2016 |
| Glaucoma Management: Combination Products |
06/01/2016 |
| Tips for Improved Administration of Eye Drops |
06/01/2016 |
| Glaucoma Management: Resources for More Information |
06/01/2016 |
| New Drugs Approved in 2015: Selected New Drugs |
05/01/2016 |
| New Drugs Approved in 2015: A Brief Description of Selected New Drugs |
05/01/2016 |
| Assessment of Asthma Control in Young Children Compared with Older Children |
04/01/2016 |
| Stepwise Approach to Asthma Treatment |
04/01/2016 |
| Common Medications for Pediatric Asthma |
04/01/2016 |
| Total Daily Doses of Selected Inhaled Corticosteroids (micrograms) |
04/01/2016 |
| Updates in Pediatric Asthma: Resources |
04/01/2016 |
| Updates in Pediatric Asthma: More Information |
04/01/2016 |
| Updates in Pediatric Asthma: Asthma Triggers |
04/01/2016 |
| Selected Antimicrobials Considered to Pose Low Risks For Pregnancy and Lactation |
03/01/2016 |
| Selected Antimicrobials Usually Avoided in Pregnancy and/or Lactation |
03/01/2016 |
| Antimicrobials in Pregnancy and Lactation: Resources |
03/01/2016 |
| Selected Interactions Between Antibiotics and Hormonal Contraceptives |
03/01/2016 |
| Selected Interactions Between Antibiotics and Hormonal Contraceptives: FDA Risk Categories for Pregnancy |
03/01/2016 |
| Antimicrobials in Pregnancy and Lactation: Lactation Risk Categories |
03/01/2016 |
| Prescription Drug Labeling Sections 8.1 – 8.3 |
03/01/2016 |
| Causes of the Common Cold |
02/01/2016 |
| Common Upper Respiratory Symptoms and Conditions |
02/01/2016 |
| Selected OTC Cough/Cold Medications a FDA Approved Dosing |
02/01/2016 |
| Selected OTC Antipyretics |
02/01/2016 |
| Managing Colds, Coughs, & Fever in Children: Resources for More Information |
02/01/2016 |
| Hormonal Therapy for Breast Cancer |
01/01/2016 |
| Oral NonHormonal Therapy For Advanced Breast Cancer |
01/01/2016 |
| Sources For Help With Medication Costs |
01/01/2016 |
| Recommendations for Nutrition and Physical Activity |
01/01/2016 |
| Breast Cancer Staging |
01/01/2016 |
| Follow-up Therapy for Hormonal Treatment of Metastatic ER/PR Positive Breast Cancer |
01/01/2016 |
| Adjuvant Hormonal Therapy in ER/PR Positive Breast Cancer - NCCN Recommendations |
01/01/2016 |
| AACE/ACE 2015 Glycemic Control Algorithm |
12/01/2015 |
| Diabetes Update: Resources |
12/01/2015 |
| SGLT-2 Inhibitor Warnings & Precautions |
12/01/2015 |
| SGLT-2 Inhibitors for Diabetes Treatment |
12/01/2015 |
| A1C and Blood Sugar Goals |
12/01/2015 |
| Individualized A1C Goals |
12/01/2015 |
| Glucose Handling in the Kidney |
12/01/2015 |
| Ominous Octet: Eight Factors Contributing to Hyperglycemia |
12/01/2015 |
| Heart Failure: ACCF/AHA Stages of HF and NYHA Functional Classification |
11/01/2015 |
| Pathophysiologic Mechanism of Heart Failure and Major Sites of Drug Action |
11/01/2015 |
| Selected Drugs/Drug Classes That Can Worsen Heart Failure |
11/01/2015 |
| Selected Medications for Chronic Heart Failure |
11/01/2015 |
| Stages in the Development of Heart Failure and Recommended Drug Therapy by Stage |
11/01/2015 |
| Some Medications For Heart Failure |
11/01/2015 |
| Heart Failure: Resources for More Information |
11/01/2015 |
| Examples of Overdose Education & Naloxone Distribution (OEND) Practice Models |
10/01/2015 |
| Naloxone Formulations |
10/01/2015 |
| Risk Factors for Opioid Misuse, Overdose, and/or Overdose Death |
10/01/2015 |
| Opioid Overdose & Naloxone Rescue Kits: Resources |
10/01/2015 |
| Opioid Timeline |
10/01/2015 |
| How To Avoid Opioid Overdose |
10/01/2015 |
| Report Any Naloxone Side Effects |
10/01/2015 |
| Opioids: If You Suspect An Overdose |
10/01/2015 |
| Travel Health: Selected Travel Immunizations |
09/01/2015 |
| Travel Health: Selected Drugs for Malaria Prevention |
09/01/2015 |
| Travel Health: Steps to Avoid Contaminated Food & Water |
09/01/2015 |
| Travel Health: Treatment of Traveler’s Diarrhea |
09/01/2015 |
| Bipolar Disorder: Common Side Effects and Management Strategies |
07/01/2015 |
| Lithium and Anticonvulsants for the Treatment of Bipolar Disorder |
07/01/2015 |
| Bipolar Disorder: Comparing Second Generation (SGA) Antipsychotics |
07/01/2015 |
| New Drugs 2014-2015 Part 2: Selected New Drugs |
05/26/2015 |
| New Drugs 2014-1015 Part 2: A Brief Description of Selected New Drugs and Formulations |
05/26/2015 |
| New Drugs 2014-2015 Part 2: Selected New Combinations and Formulations |
05/26/2015 |
| Pharmacists & Test Ordering: Examples of Monitoring Requirements for Moderate to High-Risk Medications |
04/29/2015 |
| Pharmacists & Test Ordering: Key Principals When Ordering and Interpreting Test Results |
04/29/2015 |
| What is a Collaborative Practice Agreement? |
04/29/2015 |
| Keys to Quality Improvement in Test Ordering, Interpretation of Results, and Management21 |
04/29/2015 |
| Laboratory Tests Recommended for Patients on Common Medications |
04/29/2015 |
| Pharmacists & Test Ordering: Resources for More Information |
04/29/2015 |
| Table 1. Selected New Drugs 2014-2015 (Part1) |
03/30/2015 |
| Table 2. A Brief Description of Selected New Drugs 2014-2015 (Part1) |
03/30/2015 |
| Clinical Trials Evaluating Direct-Acting Oral Anticoagulants |
03/30/2015 |
| Comparative Advantages of Direct-acting Oral Anticoagulants vs Warfarin |
03/30/2015 |
| Direct Acting Oral Anticoagulants Resources For More Information |
03/30/2015 |
| Direct Acting Oral Anticoagulants |
03/30/2015 |
| DOAC_Warning Signs_of_a_Stroke |
03/30/2015 |
| Selected CYP3A4 and P-gp Interactions with Direct-Acting Oral Anticoagulants |
03/30/2015 |
| Antithrombotic Therapy for Nonvalvular AF According to Various Guidelines |
03/29/2015 |
| Staph Infection Prevention |
02/01/2015 |
| Methicillin-Resistant Staphylococcus aureus: Resources for More Information |
02/01/2015 |
| Comparison of Hospital-Associated MRSA and Community-Associated-MRSA |
02/01/2015 |
| Oral Agents for the Treatment of Community-Associated MRSA |
02/01/2015 |
| Intravenous Agents for the Treatment of Serious MRSA Infections |
02/01/2015 |
| Single Tablet Fixed Dose Combination (FDC) Regimens for Initial Treatment of HIV Treatment-Naïve Patients |
01/01/2015 |
| DHHS/IAS Antiretroviral Therapy Recommendations for Initial HIV Therapy |
01/01/2015 |
| Selected Integrase Inhibitor Drug Interactions |
01/01/2015 |
| HIV Pharmacological Enhancer (CYP3A4 booster) |
01/01/2015 |
| Selected Contraindications and Drug Interactions with Cobicistat (in combination with Atazanavir or Darunavir) |
01/01/2015 |
| HIV Online Resources |
01/01/2015 |
| Selected FDA-Approved Antiretroviral Agents for Treatment of HIV Infection |
01/01/2015 |
| Selected Causes of Medication Errors During the Medication Use Process |
12/01/2014 |
| IOM Recommendations Specific to Pharmacy to Prevent Medication Errors |
12/01/2014 |
| Key Elements of the Medication-Use System |
12/01/2014 |
| Tools and Resources Related to Medication Safety |
12/01/2014 |
| Some Potential e-Prescribing Benefits |
12/01/2014 |
| Make Sure Your Prescription Label is “Right 5 Ways” |
12/01/2014 |
| Patient Safety: Avoiding Med Errors Resources for More Information |
12/01/2014 |
| Health Consequences of Smoking |
11/01/2014 |
| Clinically Significant Drug Interactions with Tobacco Smoke |
11/01/2014 |
| Ask, Advise, Refer Method for Tobacco Cessation Counseling |
11/01/2014 |
| Smoking Cessation Counseling Tips |
11/01/2014 |
| Smoking Cessation: Resources for More Information |
11/01/2014 |
| FDA-Approved Medications for Smoking Cessation |
11/01/2014 |
| Low-Dose Oral Contraceptives and Progestin-only Oral Contraceptives |
10/01/2014 |
| Selected Clinically Significant Interactions with Estrogen-Containing Contraceptives (OCs, patch, vaginal ring) |
10/01/2014 |
| What To Do For Missed Oral Contraceptive Pills |
10/01/2014 |
| Contraception: Resources for More Information |
10/01/2014 |
| Contraception: Resources for Providers |
10/01/2014 |
| Relative Effectiveness of Contraceptive Methods |
10/01/2014 |
| Management of Some Combined Oral Contraceptive Side Effects |
10/01/2014 |
| Hypertension Management: Classification of Blood Pressure |
09/01/2014 |
| Hypertension Management: Selected Antihypertensive Drugs |
09/01/2014 |
| Hypertension Management: JNC8 Drug Treatment Algorithm |
09/01/2014 |
| Hypertension Management: Key Lifestyle Recommendations For People with High Blood Pressure |
09/01/2014 |
| Hypertension Management: Resources for More Information |
09/01/2014 |
| Selected New Drugs 2013-2014 |
07/01/2014 |
| A Brief Description of Selected New Drugs 2013-2014 |
07/01/2014 |
| Indirect Costs Associated with Diabetes |
06/01/2014 |
| Criteria for the Diagnosis of Diabetes |
06/01/2014 |
| Screening Strategies for Gestational Diabetes During Weeks 24–28 of Pregnancy |
06/01/2014 |
| Use of Metformin in CKD |
06/01/2014 |
| Diabetes Care in the Hospital |
06/01/2014 |
| ADA Risk Factors For Diabetes |
06/01/2014 |
| Diabetes Update 2014: Resources for More Information |
06/01/2014 |
| Single-Formulation, Routine Vaccinations |
05/01/2014 |
| 2014 Age-Based Immunization Schedule |
05/01/2014 |
| 2014 Medical and Other Indications-Based Immunization Schedule |
05/01/2014 |
| Selected Vaccine Components That Can Cause Allergic Reactions |
05/01/2014 |
| Immunization Vaccines: Resources for More Information |
05/01/2014 |
| Acute Otitis Media: Basic Ear Anatomy |
04/01/2014 |
| Selected Risk Factors for Acute Otitis Media |
04/01/2014 |
| Acute Otitis Media: Facts For Caregivers |
04/01/2014 |
| Initial Management of Acute Otitis Media (AOM) without Otorrhea |
04/01/2014 |
| Acute Otitis Media: Recommended Antibiotics for Initial Treatment |
04/01/2014 |
| Acute Otitis Media: Recommended Antibiotic Treatment after Failure of Initial Antibiotic |
04/01/2014 |
| Acute Otitis Media: Resources for More Information |
04/01/2014 |
| High, Moderate and Low Intensity Statin Regimens |
03/01/2014 |
| ACC/AHA Recommendations for Statin Therapy |
03/01/2014 |
| Conditions That May Increase Risk of Statin Adverse Effects |
03/01/2014 |
| Selected Statin Drug Interactions |
03/01/2014 |
| Cholesterol Management Update: Heart-Healthy Lifestyle Habbits |
03/01/2014 |
| Cholesterol Management Update: Resources for More Information |
03/01/2014 |
| Selected New Anti-Cancer Medications |
02/01/2014 |
| A Brief Description of Selected Anti-Cancer Medications |
02/01/2014 |
| Pain Relief Ladder |
01/01/2014 |
| Selected Opioid Analgesics |
01/01/2014 |
| Non-Narcotic Medications Used for Chronic Pain |
01/01/2014 |
| Chronic Pain Management: Resources for More Information |
01/01/2014 |
| Presenting Clinical Features of Multiple Sclerosis |
12/01/2013 |
| Treatment Options for Symptomatic Problems Associated with Multiple Sclerosis |
12/01/2013 |
| Selected Disease-Modifying Drugs Approved for Relapsing Forms of Multiple Sclerosis |
12/01/2013 |
| Disease Modifying Drugs (DMDs) for Multiple Sclerosis |
12/01/2013 |
| Multiple Sclerosis: Resources for More Information |
12/01/2013 |
| Examples of Pharmacokinetic Interactions to Dietary Supplement-Drug Interactions: Examples of Pharmacokinetic Interactions |
11/01/2013 |
| Examples of Pharmacodynamic Interactions to Dietary Supplement-Drug Interactions: Examples of Pharmacodynamic Interactions |
11/01/2013 |
| Assessing Drug Interaction Likelihood and Severity |
11/01/2013 |
| Selected Drugs that Prolong the QT Interval |
11/01/2013 |
| Selected Dietary Supplement Interactions to Selected Dietary Supplement-Drug Interactions |
11/01/2013 |
| Resources for More Information on Dietary Supplements |
11/01/2013 |
| Influenza Vaccine Abbreviations |
09/01/2013 |
| Influenza Vaccines for 2013-14 Influenza Season |
09/01/2013 |
| Seasonal Influenza Vaccine Dosing Algorithm for Children Younger than 9 Year |
09/01/2013 |
| Influenza Vaccine Contraindications and Precautions |
09/01/2013 |
| Algorithm for Influenza Vaccination in Persons Allergic to Eggs |
09/01/2013 |
| Is It a Cold or the Flu? |
09/01/2013 |
| Patients at High Risk for Flu Complications |
09/01/2013 |
| Influenza Managemnt: Pain Relievers and Fever-Reducing Medications |
09/01/2013 |
| FDA Approved Uses for Selected Antipsychotic Medications |
07/01/2013 |
| Off-Label Uses of SGAs – Strength of Evidence |
07/01/2013 |
| Comparative Risks for Antipsychotic Adverse Effects |
07/01/2013 |
| Monitoring for Antipsychotic Adverse Effects |
07/01/2013 |
| Antipsychotic Medications |
07/01/2013 |
| Antipsychotics: Resources for More Information |
07/01/2013 |
| Drug Therapy in Elders: Clinical Tips Good Sleep Habits |
06/01/2013 |
| Medication Tips for Elders |
06/01/2013 |
| Drug Therapy in Elders: Clinical Tips Resources for More Information |
06/01/2013 |
| Drugs to Avoid or Closely Monitor in Elders |
06/01/2013 |
| Drugs That Most Often Impair Cognition in Elders |
06/01/2013 |
| Drugs That Can Cause or Contribute to Insomnia |
06/01/2013 |
| Approximate Equivalent Doses of Some Benzodiazepines |
06/01/2013 |
| Recommendations for Managing Hypertension in Patients with Diabetes |
05/01/2013 |
| Stages of Chronic Kidney Disease |
05/01/2013 |
| Risk Factors for Diabetic Kidney Disease or Its Progression |
05/01/2013 |
| Typical Characteristics of Childhood T2DM |
05/01/2013 |
| Recommended Times and Conditions for Testing Blood Sugar |
05/01/2013 |
| Diabetes update: Keeping Kidneys Healthy |
05/01/2013 |
| Diabetes Update: Resources for More Information |
05/01/2013 |
| DMARDs for Established Rheumatoid Arthritis: Progression of Therapy |
04/01/2013 |
| TNF Inhibitors For Rheumatoid Arthritis |
04/01/2013 |
| Selected Non–TNF Inhibitor Biologics For Rheumatoid Arthritis |
04/01/2013 |
| Rheumatoid Arthritis: Resources for More Information |
04/01/2013 |
| A Brief Description of Selected New Drugs 2012 - 2013 |
03/01/2013 |
| Selected New Drugs 2012 - 2013 |
03/01/2013 |
| Indirect Comparison of Lorcaserin and Phentermine/Topiramate |
03/01/2013 |
| Urinary Incontinence Types and Symptom Syndromes |
02/01/2013 |
| Some Drugs That May Cause or Worsen Urinary Symptoms/Incontinence |
02/01/2013 |
| Antimuscarinic Drugs for Urge Incontinence and Overactive Bladder |
02/01/2013 |
| Urinary Incontinence: Training Techniques |
02/01/2013 |
| Urinary Incontinence: Lifestyle changes |
02/01/2013 |
| Urinary Incontinence: Resources for More Information |
02/01/2013 |
| What to Look for on a Probiotic Label |
01/01/2013 |
| Regulatory Standards Recommended for Probiotics |
01/01/2013 |
| Selected Oral Probiotic Products Used in Children |
01/01/2013 |
| Probiotics Use in Children: Resources for More Information |
01/01/2013 |
| Some Types and Causes of Neuropathic Pain |
12/01/2012 |
| Selected Antidepressants for Chronic Neuropathic Pain |
12/01/2012 |
| Selected Anticonvulsants for Chronic Neuropathic Pain |
12/01/2012 |
| Differences Between Neuropathic Pain and Muscle Pain |
12/01/2012 |
| Chronic Neuropathic Pain: Resources For More Information |
12/01/2012 |
| GOLD Patient Classification and Recommended Management of COPD |
11/01/2012 |
| FDA Approved Medications for the treatment of stable COPD |
11/01/2012 |
| COPD: Resources for More Information |
11/01/2012 |
| Selected Antimicrobials Considered to Pose Low Risks in Pregnancy and Lactation, or Where Benefits Clearly Outweigh Risks |
10/01/2012 |
| Selected Antimicrobials Usually Avoided in Pregnancy and Lactation Unless Compelling Indication Exists |
10/01/2012 |
| FDA Risk Categories for Pregnancy |
10/01/2012 |
| Lactation Risk Categories |
10/01/2012 |
| Steps in the Medication Use Process Where Errors May Occur |
09/01/2012 |
| Medicine Administration Errors: Selected Online Counseling Resources |
09/01/2012 |
| Medicine Administration Errors: Key Strategies to Promote Adherence |
09/01/2012 |
| Preventing Medication Admin Errors: Medication Use Pictograms |
09/01/2012 |
| Read Your Prescription Label. Make Sure it is Right in 5 Ways |
09/01/2012 |
| Making a Medication List |
09/01/2012 |
| Stages of Melanoma |
07/01/2012 |
| Choice of Therapy for Metastatic Melanoma |
07/01/2012 |
| Metastatic Melanoma: General Principles of Ipilimumab Immune-Related Side Effect Management |
07/01/2012 |
| Metastatic Melanoma: Ipilimumab Immune-Related Side Effects |
07/01/2012 |
| Metastatic Melanoma: Selected Vemurafenib Interactions |
07/01/2012 |
| Melanoma Prevention |
07/01/2012 |
| Melanoma: Resources for More Information |
07/01/2012 |
| Selective Serotonin Reuptake Inhibitors (SSRIs) |
06/01/2012 |
| Multiple Mechanism Second Generation Antidepressants |
06/01/2012 |
| Antidepressants: Selected Clinically Significant Drug Interactions |
06/01/2012 |
| Counseling Checklist for Individuals Starting an Antidepressant |
06/01/2012 |
| Depression: Resources for More Information |
06/01/2012 |
| Clinical Presentations of Major Depressive Disorder (MDD) |
06/01/2012 |
| Depression: Patient Health Questionnaire-9 |
06/01/2012 |
| ADA Definitions for Hyperglycemia and Hypoglycemia |
05/01/2012 |
| Selected Drugs Linked with Hypoglycemia |
05/01/2012 |
| Selected Drugs Linked with Hyperglycemia |
05/01/2012 |
| Common Symptoms of Low and High Blood Sugar |
05/01/2012 |
| Treatment of Low Blood Sugar |
05/01/2012 |
| Diabetes Resources for More Information |
05/01/2012 |
| Selected New Drugs, Indications, and Dosage Forms 2011-2012 |
04/01/2012 |
| A Brief Description of Selected New Drugs 2011-2012 |
04/01/2012 |
| Significant New Dosage Forms 2011-2012 |
04/01/2012 |
| Traveler’s Diarrhea: Steps to Avoid Contaminated Food & Water |
03/01/2012 |
| Treatment of Traveler’s Diarrhea |
03/01/2012 |
| Selected Travel Immunizations |
03/01/2012 |
| Travel Medicine Resources |
03/01/2012 |
| Selected Drugs for Malaria Prevention |
03/01/2012 |
| Identifying Appropriate Candidates for Hepatitis C Antiviral Therapy |
02/01/2012 |
| Antiviral Treatment for Chronic Hepatitis C Infection |
02/01/2012 |
| Antiviral Agents for Hepatitis C Treatment: Selected Drug Interactions for Boceprevir and Telaprevir |
02/01/2012 |
| Are You At Risk for Hepatitis C? |
02/01/2012 |
| Herbal Supplements That May Cause Liver Damage |
02/01/2012 |
| Boceprevir-Based Regimens for Hepatitis C Virus Genotype 1 Infected-Patients: Response Guided Therapy |
02/01/2012 |
| Telaprevir-Based Regimens for Hepatitis C Virus Genotype 1 Infected-Patients: Response Guided Therapy |
02/01/2012 |
| IHS Migraine Diagnostic Criteria |
01/01/2012 |
| Migraine: Selected Medications for Rescue Treatment |
01/01/2012 |
| Selected Rescue and Preventive Medications for Migraine Management |
01/01/2012 |
| Common Migraine Triggers |
01/01/2012 |
| Migraine Resources |
01/01/2012 |
| Migraine: Selected Medications for Preventive Therapy |
01/01/2012 |
| Selected Herbs and Dietary Supplements for Migraine Prevention |
01/01/2012 |
| FDA Definition of Serious Adverse Events |
12/01/2011 |
| Adverse Drug Reactions: Selected free Informaiton Sources |
12/01/2011 |
| Southern Network on Adverse Reactions (SONAR) Data Sources |
12/01/2011 |
| Adverse Drug Reactions: Types of Information Extracted From Data Sources Using the SONAR Methodology |
12/01/2011 |
| Patient Safety: Patient Responsibilities |
12/01/2011 |
| Adverse Drug Reactions: How to Report to MedWatch |
12/01/2011 |
| Patient Safety: Resources for More Information |
12/01/2011 |
| HIV: Preferred Antiretroviral Regimens for Initial Therapy |
11/01/2011 |
| HIV: Antiretroviral Agents to Avoid |
11/01/2011 |
| Selected Antiretroviral Agents for the Treatment of HIV Infection |
11/01/2011 |
| HIV: Selected Antiretroviral Drug Interactions |
11/01/2011 |
| Online HIV Resources |
11/01/2011 |
| Stages of Chronic Kidney Disease |
10/01/2011 |
| Selected Causes of Chronic Kidney Disease |
10/01/2011 |
| Chronic Kidney Disease - Free Online Resources |
10/01/2011 |
| Drug-Induced Nephrotoxicity |
10/01/2011 |
| Selected Drugs That May Impair Kidney Function |
10/01/2011 |
| Chronic Kidney Disease - Resources for More Information |
10/01/2011 |
| Over-the-Counter Medicines That May Be Harmful in Chronic Kidney Disease |
10/01/2011 |
| National Standards on Culturally and Linguistically Appropriate Services (CLAS) in Health Care |
09/01/2011 |
| United States Pharmacopeia (USP) Advisory Panel Recommendations to Improve Prescription Drug Labels |
09/01/2011 |
| Anticoagulant Sites of Action |
07/01/2011 |
| Anticoagulant Classes and Agents |
07/01/2011 |
| Comparing the Pharmacokinetics of Selected New Anticoagulants and Warfarin |
07/01/2011 |
| Converting Between Dabigatran and Warfarin |
07/01/2011 |
| Venous Clots: Factors and Symptoms |
07/01/2011 |
| Pluses and Minuses of Dabigatran (Pradaxa®) Compared to Warfarin |
07/01/2011 |
| Resources for Information on Blood Clots |
07/01/2011 |
| Antibiotic Resources |
06/01/2011 |
| Should an Antibiotic be Used? |
06/01/2011 |
| Slowing the Spread of Antibiotic Resistant Bacteria |
06/01/2011 |
| Clostridium difficile Infection (CDI) Treatment Recommendations |
06/01/2011 |
| Community-Associated MRSA vs. Healthcare-Associated MRSA |
06/01/2011 |
| Oral Treatment Options for Some Community-Associated Infections |
06/01/2011 |
| Supplements for the Management of Cognitive Decline and Dementia |
05/01/2011 |
| Healthy Habbits That May Help Prevent Cognitive Loss and Dementia |
05/01/2011 |
| Resources for Memory Improvement and Dementia Management Supplements |
05/01/2011 |
| New Combination Products 2011-2012 |
04/01/2011 |
| Drugs Commonly Associated With Weight Gain |
04/01/2011 |
| Classification of Overweight and Obesity by BMI |
04/01/2011 |
| Clinical Identification of the Metabolic Syndrome |
04/01/2011 |
| FDA-Approved Agents for Weight Loss |
04/01/2011 |
| Obesity Management: Behavioral Changes |
04/01/2011 |
| Resources for Obesity Management |
04/01/2011 |
| Selected New Drugs 2010-2011 |
03/01/2011 |
| A Brief Description of Selected New Drugs 2010-2011 |
03/01/2011 |
| New Combination Products 2010-2011 |
03/01/2011 |
| Fixed Combination Products for Hypertension & Type 2 Diabetes |
03/01/2011 |
| New Dosage Forms 2010-2011 |
03/01/2011 |
| Treatment Recommendations for Adults 65 Years of Age & Older with Diabetes |
02/01/2011 |
| Risk Factors for Hypoglycemia in Older Adults with Diabetes |
02/01/2011 |
| REMS Conditions for Rosiglitazone |
02/01/2011 |
| Common Symptoms of Hypoglycemia |
02/01/2011 |
| Non-Insulin Medications for the Treatment of Type 2 Diabetes |
02/01/2011 |
| Common Side Effects of Diabetes Medications |
02/01/2011 |
| Treatment of Hypoglycemia |
02/01/2011 |
| Adult Diabetes Resources |
02/01/2011 |
| Currently Available Insulins For Diabetes |
02/01/2011 |
| Algorithm For The Management Of Restless Legs Syndrome (RLS) |
01/01/2011 |
| Selected Medications for the Treatment of Restless Leg Syndrome (RLS) |
01/01/2011 |
| Non-Drug Treatments for Restless Legs Syndrome |
01/01/2011 |
| Restless Legs Syndrome Diagnosis |
01/01/2011 |
| Restless Legs Syndrome Resources |
01/01/2011 |
| Common Medication Administration Errors By Caregivers |
12/01/2010 |
| Ten Potentially Dangerous OTC Products in Children |
12/01/2010 |
| Case 1 - Selecting the Appropriate Acetaminophen Formulation |
12/01/2010 |
| Case 2 - Accurate Dose Measurement |
12/01/2010 |
| Key Points in Educating Caregivers on the Use of Medications in Children |
12/01/2010 |
| Case 3 - Dehydration Assessment & Treatment |
12/01/2010 |
| Measuring Temperature |
12/01/2010 |
| When to Contact a Primary Care Provider |
12/01/2010 |
| Expanding Your Knowledge of Pediatric Drug Therapy |
12/01/2010 |
| The Rx Consultant's Top 10 Lists |
12/01/2010 |
| 10 Potentially Dangerous OTC Drugs In Children |
12/01/2010 |
| 10 Potentially Hazardous Drug Issues For Elders |
12/01/2010 |
| 10 Error-Prone Abbreviations |
12/01/2010 |
| 10 Common Medication Errors |
12/01/2010 |
| 10 Counseling Points For Medication Error Prevention |
12/01/2010 |
| 10 Potential Interactions: Commonly Prescribed Drugs |
12/01/2010 |
| 10 Potential Interactions_Warfarin and Commonly Prescribed Drugs |
12/01/2010 |
| 10 Potential Interactions_Warfarin and Commonly Prescribed Drugs |
12/01/2010 |
| 10 Potential Interactions_OTCs and Commonly Prescribed Drugs |
12/01/2010 |
| Patients at Risk For Influenza Complications |
11/01/2010 |
| Available Vaccines For The 2010-11 Influenza Season |
11/01/2010 |
| Neuraminidase Inhibitors for Influenza |
11/01/2010 |
| Vaccines For Influenza |
11/01/2010 |
| Vaccines For Influenza |
11/01/2010 |
| Influenza Symptoms |
11/01/2010 |
| Resources For More Information On Influenza |
11/01/2010 |
| Diagnostic Criteria For PTSD |
10/01/2010 |
| Primary Care PTSD Screen |
10/01/2010 |
| Medication Effects On PTSD Symptom Clusters |
10/01/2010 |
| Medications Used in the Treatment of Post Traumatic Stress Disorder |
10/01/2010 |
| Select Clinically Significant Drug Interactions For Post Traumatic Stress Disorder |
10/01/2010 |
| Vitamin D [25(OH)D] Serum Levels |
09/01/2010 |
| Definition Of Terms For Vitamin D |
09/01/2010 |
| Vitamin D Formation |
09/01/2010 |
| Daily Vitamin D Intake Recommendations |
09/01/2010 |
| Select Vitamin D - Drug Interactions |
09/01/2010 |
| Factors That Increase the Likelihood of Vitamin D Deficiency |
09/01/2010 |
| Food Sources of Vitamin D |
09/01/2010 |
| Classification of Blood Pressure in Adults |
07/01/2010 |
| Commonly Prescribed Antihypertensive Agents For Hypertension |
07/01/2010 |
| Drug Combination Recommendations for the Treatment of Hypertension |
07/01/2010 |
| Compelling Indications and Recommended Drugs For Hypertension |
07/01/2010 |
| The American Heart Association: 10 Ways to Control Your High Blood Pressure |
07/01/2010 |
| Resources For More Information On Hypertension |
07/01/2010 |
| Classification of Asthma Severity in Persons 12 Years of Age and Older |
06/01/2010 |
| Assessment of Asthma Control and Adjusting Therapy in Persons 12 Years of Age and Older |
06/01/2010 |
| Stepwise Approach for Management of Asthma |
06/01/2010 |
| Inhaled Corticosteroids for The Treatment of Asthma |
06/01/2010 |
| Potential Asthma Triggers |
06/01/2010 |
| Resources for Asthma Management |
06/01/2010 |
| Classification of Asthma Severity In Children 0-4 Years of Age |
06/01/2010 |
| Classification of Asthma Severity In Children 5-11 Years of Age |
06/01/2010 |
| Assessment of Asthma Control and Adjusting Therapy In Children 0-4 Years of Age |
06/01/2010 |
| Assessment of Asthma Control and Adjusting Therapy In Children 5-11 Years of Age |
06/01/2010 |
| Medications Used in Managing Acute Exacerbations of Asthma |
06/01/2010 |
| Priming Recommendations for Commonly Used Inhalers |
06/01/2010 |
| Asthma Device Technique Summary |
06/01/2010 |
| Examples of Potential Dietary Supplement-Anticancer Drug Interactions |
05/01/2010 |
| Metabolic Pathways for Selected Chemotherapy Agents |
05/01/2010 |
| Selected Chemotherapy Agents that are P-glycoprotein Substrates |
05/01/2010 |
| Evaluating Potential Dietary Supplement – Chemotherapy Agent Interactions |
05/01/2010 |
| Common Treatments for Hormone-Dependent Breast Cancer |
05/01/2010 |
| Anticancer Agent - Dietary Supplement Interactions Hallmark Chemotherapy Side Effects |
05/01/2010 |
| Getting Dietary Supplement Information from the Internet |
05/01/2010 |
| Resources For Dietary Supplement-Anticancer Drug Interactions Anticancer Drug Interactions |
05/01/2010 |
| Stimulant Drugs Used in the Treatment of ADHD |
04/01/2010 |
| Stimulant Adverse Effects and Their Management for ADHD |
04/01/2010 |
| Nonstimulant Drugs for ADHD |
04/01/2010 |
| Stimulant and Nonstimulant Drugs Interactions for ADHD |
04/01/2010 |
| Clinical Presentation of ADHD Across The Life Cycle |
04/01/2010 |
| Resources for ADHD |
04/01/2010 |
| Selected New Drugs 2009-2010 |
03/01/2010 |
| A Brief Description of Selected New Drugs 2009-2010 |
03/01/2010 |
| New Combination Products and Significant New Dosage Forms 2009-2010 |
03/01/2010 |
| Resources: Sexually Transmitted Infections |
02/01/2010 |
| Appropriate Use of Condoms |
02/01/2010 |
| Medications for Sexually Transmitted Infections |
02/01/2010 |
| Drugs of Choice for Some Sexually Transmitted Infections |
02/01/2010 |
| Diabetes Update: Efficacy Comparison of Liraglutide to Exenatide |
01/01/2010 |
| Resources: Diabetes Therapy |
01/01/2010 |
| Diabetes Update: Mechanisms of DPP-4 Inhibitors and Incretin Mimetics |
01/01/2010 |
| Chronic Pain Management Resources |
12/01/2009 |
| The ABC’s of Pain Management |
12/01/2009 |
| Pain Relief Ladder |
12/01/2009 |
| Approximate Equianalgesic Doses of Selected Opioids for Pain Management |
12/01/2009 |
| Legal/Regulatory Concerns: Position of Regulators |
11/01/2009 |
| Pharmacy Law Resources |
11/01/2009 |
| The Federal Controlled Substances Act |
11/01/2009 |
| Warning Signs That Prescriptions May Not Be Legitimate |
11/01/2009 |
| Medications and Doses for the Treatment of Cold Sores |
10/01/2009 |
| Online Resources for Additional Information About Cold Sores |
10/01/2009 |
| Some Products Used for the Management of Cold Sores |
10/01/2009 |
| Selected Products Used for Cold Sores: Mechanisms of Action |
10/01/2009 |
| National Coordinating Council for Medication Error Reporting and Prevention: Recommendations for Enhancing Dispensing Accuracy |
09/01/2009 |
| Look-Alike Sound-Alike Errors with the Top 5 Brand & Generic Drugs of 2008 |
09/01/2009 |
| Medication Errors: Selected Dangerous Abbreviations and Dose Designations |
09/01/2009 |
| Medication Error Prevention: Safe Labels for Community Pharmacy Prescription Vials |
09/01/2009 |
| Key Information to Convey to Patients with Each New Prescription |
09/01/2009 |
| More Resource Information To Prevent Medication Errors |
09/01/2009 |
| Recommendations for Patient Medication Safety |
09/01/2009 |
| Prevent Medication Errors: Read Your Label. Be Sure It is Right in 5 Ways |
09/01/2009 |
| Resources for Further Information for Patients on Medication Errors |
09/01/2009 |
| Units of Measure for Liquid Medications |
09/01/2009 |
| Considerations in Cytochrome P450- Mediated Interactions |
07/01/2009 |
| Metabolic Fate of Antipsychotic Medications |
07/01/2009 |
| Comparative Inhibition of CYP2D6 |
07/01/2009 |
| Can SSRIs Be Prescribed With Triptans? |
07/01/2009 |
| Psychotropics - Drug Interactions and the Cytochrome P450 System |
07/01/2009 |
| Some Medications That May Cause Serotonin Syndrome |
07/01/2009 |
| Clinical Appearance and Distribution of Eczema in Infants, Children and Adults |
06/01/2009 |
| Diagnostic Criteria for Eczema in Children |
06/01/2009 |
| Stepwise Approach to Management of Childhood Eczema |
06/01/2009 |
| Resources for Eczema |
06/01/2009 |
| Relative Potency of Selected Topical Corticosteroids used in Children |
06/01/2009 |
| FDA Health Advisory for Antipsychotics in Older Adults |
05/01/2009 |
| Second Generation Antipsychotics Used to Treat Behavioral and Psychological Symptoms of Dementia (BPSD) |
05/01/2009 |
| Risk of Serious Adverse Events from Use of Second Generation Antipsychotics in Older Demented Adults |
05/01/2009 |
| Considerations Before Starting Medication for the Treatment of Behavioral and Psychological Symptoms of Dementia |
05/01/2009 |
| Non-drug Approaches to Managing Behavioral and Psychological Symptoms of Dementia |
05/01/2009 |
| Managing Behavioral and Psychological Symptoms of Dementia: Resources for Patients and Families |
05/01/2009 |
| Drug Therapy for Behavioral and Psychological Symptoms of Dementia |
05/01/2009 |
| 2008-2009 Selected New Drugs |
04/01/2009 |
| A Brief Description of Selected New Drugs 2008-2009 |
04/01/2009 |
| Selected New Formulations FDA Approved in 2008 |
04/01/2009 |
| Selected New Combination Products FDA Approved in 2008 |
04/01/2009 |
| Osteoporosis Medications |
03/01/2009 |
| Medications for the Prevention And Treatment of Osteoporosis |
03/01/2009 |
| Medications for Osteoporosis Treatment and Prevention |
03/01/2009 |
| Risk Factors for Osteoporosis and Fractures |
03/01/2009 |
| Candidates for Bone Mineral Density Testing |
03/01/2009 |
| Recommended Daily Calcium and Vitamin D Intake |
03/01/2009 |
| Contraindications and Precautions for Some Adult Vaccines Administered by Pharmacists |
02/01/2009 |
| Vaccines for Adolescents and Adults |
02/01/2009 |
| Vaccines: Considerations For Pregnant Women |
02/01/2009 |
| Patient Resources for Adult Immunizations |
02/01/2009 |
| Factors That Alter PSA Levels for Prostate Cancer |
01/01/2009 |
| Luteinizing Hormone-Releasing Hormone (LHRH) Agonists for the Treatment of Prostate Cancer |
01/01/2009 |
| Experimental Treatments for Prostate Cancer |
01/01/2009 |
| Antiandrogens for the Treatment of Prostate Cancer |
01/01/2009 |
| TNM Staging System for Prostate Cancer |
01/01/2009 |
| Antiretroviral Agents for the Treatment of HIV Infection |
11/01/2008 |
| HIV Infection: Antiretroviral Agents To Avoid |
11/01/2008 |
| Online HIV Resources |
11/01/2008 |
| HIV Infection: Preferred HAART Regimens for Initial Therapy in Treatment-Naive Patients |
11/01/2008 |
| Adverse Effects and Potential Drug Interactions of Selected Commonly Used Weight Loss Supplements |
10/01/2008 |
| Common Dietary Supplement Ingredients Used for Weight Loss, Classified by Proposed Mechanism |
10/01/2008 |
| Common Dietary Supplements Used For Weight Loss |
10/01/2008 |
| Dietary Supplements Used For Weight Loss: Recent Federal Trade Commission Actions Against Weight-Loss Product Marketers |
10/01/2008 |
| Key Weight Loss Recommendations |
10/01/2008 |
| Dietary Supplements Used For Weight Loss: What is Hoodia? |
10/01/2008 |
| Antidepressants: Selected Clinically Significant Drug Interactions |
09/01/2008 |
| Diagnostic Criteria for Major Depressive Disorder (MDD) |
09/01/2008 |
| Multiple Mechanism Second Generation Antidepressants for the Treatment of Depression |
09/01/2008 |
| Selective Serotonin Reuptake Inhibitors (SSRIs) for the Treatment of Depression |
09/01/2008 |
| Effect of Postmenopausal Hormones on Clinical Event Risk: Findings of the WHI Studies |
07/01/2008 |
| Non-Oral Estrogens & Combination Products for the Treatment of Menopausal Vasomotor and Vaginal Symptoms |
07/01/2008 |
| Oral Estrogens & Combination Products for the Treatment of Menopausal Vasomotor and Vaginal Symptoms |
07/01/2008 |
| Some Contraindications to Postmenopausal Hormone Therapy |
07/01/2008 |
| Terminology for Menopause- Related Therapies |
07/01/2008 |
| Non-Drug Management of Cold Symptoms |
06/01/2008 |
| Cough and Cold Management: Selected Analgesic and Decongestant Medications |
06/01/2008 |
| Cough and Cold Management: Selected Antihistamines, Antitussives and Expectorants |
06/01/2008 |
| Common Upper Respiratory Symptoms and Conditions |
06/01/2008 |
| A Brief Description of Selected New Drugs: 2007-2008 |
05/01/2008 |
| Selected New Combination Products FDA Approved in 2007 |
05/01/2008 |
| Selected New Drugs: 2007-2008 |
05/01/2008 |
| Selected New Formulations FDA Approved in 2007 |
05/01/2008 |
| Criteria for Initial Antibiotic Therapy or Observation for Children with Acute Otitis Media |
05/01/2008 |
| Drugs and Supplements Used in Sports: Commonly Abused Anabolic- Androgenic Steroids |
04/01/2008 |
| Drugs and Supplements Used in Sports: Comparison of Banned/Prohibited Substances for NCAA and USADA |
04/01/2008 |
| Drugs and Supplements Used in Sports: Examples of NCAA Banned Drug Classes 2007-2008 |
04/01/2008 |
| Drugs and Supplements Used in Sports: Potential Adverse Effects of Common Performance-Enhancing Substances |
04/01/2008 |
| Drugs & Supplements Used in Sports: World Anti-Doping Agency's Definition of Doping |
04/01/2008 |
| Alzheimer's Disease & Dementia: Communicating-Counseling Tips |
03/01/2008 |
| Drugs for the Treatment of Alzheimer's Disease or Other Forms of Dementia |
03/01/2008 |
| Reducing Adverse Effects of Cholinesterase Inhibitor Therapy in the Treatment of Dementia |
03/01/2008 |
| Risk Factors Linked With Dementia |
03/01/2008 |
| Suggestions for Treating Behavioral and Psychiatric Symptoms Associated with Dementia |
03/01/2008 |
| Acute Otitis Media: Facts for Caregivers |
02/01/2008 |
| Acute Otitis Media Risk Factors |
02/01/2008 |
| Antibiotic Treatment Options for Acute Otitis Media in Children |
02/01/2008 |
| ABCR Disease Modifying Drug Regimens for Multiple Sclerosis |
01/01/2008 |
| Multiple Sclerosis: Administration Recommendations for ABCR Drugs |
01/01/2008 |
| Presenting Clinical Features of Multiple Sclerosis |
01/01/2008 |
| Treatment Options for Common Symptomatic Problems in Patients with Multiple Sclerosis |
01/01/2008 |
| Some Adverse Effects of Dietary Supplements Used in the Treatment of Cardiovascular Diseases |
12/01/2007 |
| What To Do When Consumers Ask About Dietary Supplement Use |
12/01/2007 |
| Some Potential Drug Interactions with Dietary Supplements Used in the Treatment of Cardiovascular Diseases |
12/01/2007 |
| Resources: Dietary Supplements Used in the Treatment of Cardiovascular Disease |
12/01/2007 |
| Pharmacy Law Implications for Practice: Compounding |
11/01/2007 |
| Pharmacy Law Implications for Practice: Drug Pedigrees |
11/01/2007 |
| Pharmacy Law Implications for Practice: Patient Access to Investigational Drugs |
11/01/2007 |
| Pharmacy Law Implications for Practice: Medicaid Reimbursement |
11/01/2007 |
| Pharmacy Law Implications for Practice: The Marketing of Unapproved Drugs |
11/01/2007 |
| Pharmacy Law Implications for Practice: Multiple Schedule II Prescriptions |
11/01/2007 |
| Examples of Nonselective, Partially COX-2 Selective, and Highly COX-2 Selective NSAIDs |
10/01/2007 |
| Management Strategies for Reducing Risk of NSAID-Related Gastric Ulcer in Low, Medium and High Risk Patients |
10/01/2007 |
| Oral Drug Regimens Used to Heal NSAID-Associated Peptic Ulcers and Reduce Ulcer Risk |
10/01/2007 |
| Resources: NSAIDs and Peptic Ulcer Disease |
10/01/2007 |
| Risk Factors for NSAID-Associated Gastric Ulcer and Upper GI Bleeding |
10/01/2007 |
| Health Consequences of Smoking |
09/01/2007 |
| FDA-Approved Medications for Smoking Cessation |
09/01/2007 |
| Resource Information for Smoking Cessation |
09/01/2007 |
| Smoking Cessation Counseling Tips |
09/01/2007 |
| Ask, Advise, Refer Method for Tobacco Cessation Counseling |
09/01/2007 |
| Selected Agents for the Treatment of Type 2 Diabetes |
07/01/2007 |
| Selected Insulin Formulations |
07/01/2007 |
| Algorithm for the Metabolic Management of Type 2 Diabetes |
07/01/2007 |
| Non-Insulin Medications for Type 2 Diabetes |
07/01/2007 |
| Premeal Dose Conversion Table: Exubera (mg) to Subcutaneous Regular Insulin (IU) |
07/01/2007 |
| Treatment Goals for Nonpregnant Adults with Diabetes |
07/01/2007 |
| Classification of Weight by BMI |
06/01/2007 |
| Diagnostic Criteria for Eating Disorders with Descriptive Features |
06/01/2007 |
| Drugs with Evidence for Effectiveness in Eating Disorders |
06/01/2007 |
| The Eating Attitudes Test (EAT) |
06/01/2007 |
| Specialized Eating Disorder Treatment Programs |
06/01/2007 |
| Resources for Patients with Eating Disorders |
06/01/2007 |
| Eating Disorders: Commonly Abused Over-the-Counter (OTC) Laxatives |
06/01/2007 |
| Common Dietary Supplement Ingredients Marketed for Weight Loss |
06/01/2007 |
| Antibiotic Resistance |
05/01/2007 |
| Widely Used Fluoroquinolone Agents and Common Indications |
05/01/2007 |
| Prevalence of fluoroquinolone use and resistance in S. pneumoniae and E. coli in the United States |
05/01/2007 |
| Factors that Predispose Individuals to Fluoroquinolone Adverse Effects |
05/01/2007 |
| Some Drugs that Interact with Fluoroquinolones |
05/01/2007 |
| A Brief Description of Selected New Drugs 2006-2007 |
04/01/2007 |
| Selected New Combination Products FDA Approved in 2006-2007 |
04/01/2007 |
| Selected New Drugs 2006-2007 |
04/01/2007 |
| Selected New Formulations FDA Approved in 2006-2007 |
04/01/2007 |
| Oral Contraceptives FDA Approved in 2006 |
04/01/2007 |
| Allergen Control Measures |
03/01/2007 |
| New International Classification of Allergic Rhinitis Symptoms |
03/01/2007 |
| Resource Information on Allergic Rhinitis |
03/01/2007 |
| Commonly Used Antihistamines for Allergic Rhinitis |
03/01/2007 |
| Nasal Corticosteroids for Allergic Rhinitis |
03/01/2007 |
| How to Use a Nasal Spray |
03/01/2007 |
| Comparative Symptom Relief with Medications for Allergic Rhinitis |
03/01/2007 |
| Stepwise Approach To Allergic Rhinitis Management In Adolescents and Adults |
03/01/2007 |
| Antiestrogens and Aromatase Inhibitors for Breast Cancer Therapy |
02/01/2007 |
| Resources for More Information on Breast Cancer |
02/01/2007 |
| Breast Cancer Warning Signs & Symptoms |
02/01/2007 |
| Breast Cancer Screening Recommendations from the American Cancer Society and the National Cancer Institute |
02/01/2007 |
| Prognostic Factors for Breast Cancer |
02/01/2007 |
| Factors that Increase the Risk of Breast Cancer in Women |
02/01/2007 |
| Tamoxifen Versus Aromatase Inhibitors for Breast Cancer Therapy: Major Clinical Trials |
02/01/2007 |
| Comparative Dosing of Salmeterol and Formoterol for Asthma Management |
01/01/2007 |
| Asthma Management: Highlights of the FDA Public Health Advisory Concerning the Use of LABAs |
01/01/2007 |
| Resources for Asthma Management |
01/01/2007 |
| Classification of Asthma Severity |
01/01/2007 |
| Inhaled Corticosteroids for the Treatment of Asthma in Adults |
01/01/2007 |
| Tips for Inhaler Use |
01/01/2007 |
| Stepwise Treatment Approach for Managing Asthma in Adults and Children Older Than 5 Years of Age |
01/01/2007 |
| Body Mass Index |
12/01/2006 |
| Classification of Blood Pressure in Adults |
12/01/2006 |
| Commonly Prescribed Antihypertensive Agents |
12/01/2006 |
| Compelling Indications and Recommended Drugs |
12/01/2006 |
| The DASH Diet |
12/01/2006 |
| Hypertension Management Resources |
12/01/2006 |
| Reduce Sodium in Diet |
12/01/2006 |
| Individuals for Whom Influenza Vaccination is Recommended |
11/01/2006 |
| Influenza: Resources for More Information |
11/01/2006 |
| Differences Between Influenza and the Common Cold |
11/01/2006 |
| Anti-Influenza Drugs |
11/01/2006 |
| Persons for Consideration of Influenza Prophylaxis with Oseltamivir or Zanamivir |
11/01/2006 |
| Commonly Used Analgesics for Osteoarthritis Pain |
10/01/2006 |
| Selected Combination Products for Osteoarthritis Pain |
10/01/2006 |
| Some Supplements Used for Osteoarthritis |
10/01/2006 |
| Osteoarthritis Pain Resources for Patients |
10/01/2006 |
| Some Complementary or Alternative Therapies Used for Osteoarthritis |
10/01/2006 |
| “Proximal Causes” of Medication Errors |
10/01/2006 |
| Top Drugs Most Frequently Associated With Medication Errors, 2002-2003 |
10/01/2006 |
| Look-Alike/Sound-Alike Drugs (Top Ten Drugs Prescribed in 2005) |
10/01/2006 |
| Selected Error-Prone Abbreviations and Dose Designations |
10/01/2006 |
| Medication Errors Resources |
10/01/2006 |
| Common Symptoms of Diabetic Peripheral Neuropathy |
09/01/2006 |
| Selected Medications for the Treatment of Painful Diabetic Neuropathy |
09/01/2006 |
| Symptoms of Diabetic Neuropathy |
09/01/2006 |
| Preventing Diabetic Neuropathy |
09/01/2006 |
| Selected Treatments for Diabetic Peripheral Neuropathy Pain |
09/01/2006 |
| Diabetic Neuropathy Resources |
09/01/2006 |
| A Brief Description of Selected New Drugs 2005-2006 |
07/01/2006 |
| Selected New Formulations FDA Approved in 2005-2006 |
07/01/2006 |
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.